Subject and method: A case series of 27 patients with resectable stage II, III paclitaxel / carboplatin (paclitaxel 50mg / m2, carboplatin AUC 2) for 5 weeks and concurrent radiotherapy (41.4Gy in 23 fractions), followed by esophagectomy.